2019058-10: Immunoabsorption CNTN1/Caspr1(16047 1:100)

Objective: to do an immunoabsorption of CNTN1/Caspr1 in sera from 1 patients with antibodies anti-CNTN1/Caspr1

08.05.2019: Coating HEK293

  • Prepare 3  6-well plates 
  • Treatment with Poly-D-Lysine (diluted 1/40 with boratte buffer)
  • Incubate for 1h (37ºC, 5% CO2).
  • Wash with PBS
  • Trypsin-EDTA a plate of HEK293 –> For every well: 240.000 cells
  • Incubate at 37ºC for 24h.

09.05.2019: Transfection

Transfect 3  6-well plate with CNTN1, Caspr1, CNTN1+Caspr1

  • CNTN1:
    DNA 4 µg /well; Lipofectamine 6 µL/well ; Optimen 250 µL/well
  • Caspr1:
    DNA 4 µg /well; Lipofectamine 6 µL/well ; Optimen 250 µL/well
  • CTNT1
    DNA 4 µg /well (Caspr1 1.35 µL/well ; CNTN1 2,65 µL/well ); Lipofectamine 6 µL/well ; Optimen 250 µL/well
  • Incubate the DNA and the lipofectamine at RT for 5 min.
  • Unify every DNA with the appropriate amount of Lipo and incubate at RT for 30 min.
  • For every well: 2 ml of HEK medium and 250 µL of the mix of DNA and Lipo.
  • Incubate O/N at 37ºC.

09.05.2019 : Fixing and Immunoabsorption

  • Fix  with PFA 4%. Incubation at RT during 10min.
  • Wash with PBS 1x.
  • Dilute serum 1/100 in Goat 5%. Samples:
    • Sample: 16047
  • Put 0’5 ml in the first well of every plate
  • Incubate 1 hour in every well (at RT)
  • Freeze the immunoabsorpted samples at -20ºC

13.05.2019: Comprobation (ICQ):

(same protocol we use to detec antibodies to CNTN1/Caspr1)

HEK 293 trasfected cells with CNTN1/Caspr1: all pre-absorbed sera 1:100 with CNTN1, Caspr1, and CNTN1+Caspr1 are POSITIVE.

16.05.2019: Comprobation (teasing):

(teasing protocol):

Sample 16.047 pre-absorbed with CNTN1+Caspr1: paranodal stainning (POSITIVE)

Also we tried diferent dilutions with non-absorbed seram from 16.047 patient

  • 1:500 POSITIVE
  • 1:1000 NEGATIVE

CONLUSION: Sera was not immunoabsorbed because was not diluted enough. We will try with 1:500 dilution

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.